2. Apoptosis Immunology/Inflammation MAPK/ERK Pathway NF-κB
  3. Apoptosis Interleukin Related TNF Receptor p38 MAPK NF-κB
  4. Peimine

Peimine  (Synonyms: Verticine; Dihydroisoimperialine)

Cat. No.: HY-N0212 Purity: 99.40%
COA Handling Instructions

Molarity Calculator

Peimine (Verticine; Dihydroisoimperialine) is an orally active natural product. Peimine has anti-inflammatory, analgesic and cough relieving effects. Peimine can be used in cancer and inflammation related research.

For research use only. We do not sell to patients.

Peimine Chemical Structure

Peimine Chemical Structure

CAS No. : 23496-41-5

Size Price Stock Quantity
Solid + Solvent
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 55 In-stock
Solution
10 mM * 1 mL in DMSO USD 55 In-stock
Solid
5 mg USD 50 In-stock
10 mg USD 80 In-stock
25 mg USD 150 In-stock
50 mg USD 250 In-stock
100 mg USD 400 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Peimine Related Antibodies

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Peimine

View All p38 MAPK Isoform Specific Products:

View All Isoforms
p38 MAPK p38α p38β MAPK13 p38δ p38γ

View All NF-κB Isoform Specific Products:

View All Isoforms
NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Peimine (Verticine; Dihydroisoimperialine) is an orally active natural product. Peimine has anti-inflammatory, analgesic and cough relieving effects. Peimine can be used in cancer and inflammation related research[1][2][3][4][5][6][7].

IC50 & Target

Ki-67

 

PCNA

 

IL-1

 

IL-6

 

TNF-α

 

IL-1β

 

IL-10

 

p38

 

NFκB

 

In Vitro

Peimine (0-200 μM, 24 h) disrupts intracellular calcium homeostasis through the Ca2+/CaMKII/JNK pathway, inhibits the growth and movement of prostate cancer cells (DU-145, LNCap, and PC-3) and induces apoptosis, while having no significant effect on normal cells (RWPE-1) [3].
Peimine (0-25 mg/L, 1 h) has anti-inflammatory activity through regulating TNF-a, IL-6, IL-1b and IL-10 by suppressing the phosphorylation of MAPK and the activation of NF-kB in LPS-stimulated RAW 264.7 macrophages[6].
Peimine (10-300 μM, 0-10 ms) can block the Nav1.7 ion channel with an IC50 value of 47.2 μM, and can also inhibit the Kv1.3 ion channel with an IC50 value of 354.4 μM[7].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Peimine Related Antibodies

Western Blot Analysis[3]

Cell Line: PC-3 cells
Concentration: 0-10 μM
Incubation Time: 24 h
Result: Decreased the protein expression levels of Ki-67 and PCNA in PC-3 cells in a dose-dependent manner.
In Vivo

Peimine (32.5 μM/kg/day for 7days,i.g.) can effectively alleviate LPS-induced acute lung injury in mice, inhibit the expression levels of inflammatory factors TNF-α, IL-6, and IL-1 in mouse models, and has a synergistic effect when combined with Peiminine (HY-N0213) and Forsythoside. It can effectively improve its anti-inflammatory activity[4].
The drug level of Peimine (single oral 4.25 g/kg) in the blood and tissue of male rats is significantly higher than that of female rats (Reference 3)[5].

Pharmacokinetic Analysis in male and female SD Rats[5]

Gender Route Dose (g/kg) Cmax (ng/mL) Tmax (h) t1/2 (h) MRT0-t (h) MRT0-∞ (h) AUC0-t (ng·h/mL) AUC0-∞ (ng·h/mL) CL/F (L/kg/h) V/F (L/kg)
Female p.o. 4.25 43.7 1.5 4.2 7.8 7.9 214.2 214.3 128.9 781.3
Male p.o. 4.25 57.6 2.9 6.2 7.2 7.4 662.4 665.3 41.5 374.1

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Molecular Weight

431.65

Formula

C27H45NO3
CAS No.
Appearance

Solid

Color

White to off-white

SMILES

[H][C@]12[C@]3([H])C[C@H](O)[C@@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])C[C@]([H])1[C@]5([H])CN6C[C@@H](C)CC[C@]([H])6[C@@](C)(O)[C@]([H])5CC2
Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 50 mg/mL (115.83 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.3167 mL 11.5835 mL 23.1669 mL
5 mM 0.4633 mL 2.3167 mL 4.6334 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (5.79 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
% 
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.40%

COA (258 KB) HNMR (293 KB) RP-HPLC (219 KB) MS (68 KB)

Handling Instructions (2659 KB)
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.3167 mL 11.5835 mL 23.1669 mL 57.9173 mL
5 mM 0.4633 mL 2.3167 mL 4.6334 mL 11.5835 mL
10 mM 0.2317 mL 1.1583 mL 2.3167 mL 5.7917 mL
15 mM 0.1544 mL 0.7722 mL 1.5445 mL 3.8612 mL
20 mM 0.1158 mL 0.5792 mL 1.1583 mL 2.8959 mL
25 mM 0.0927 mL 0.4633 mL 0.9267 mL 2.3167 mL
30 mM 0.0772 mL 0.3861 mL 0.7722 mL 1.9306 mL
40 mM 0.0579 mL 0.2896 mL 0.5792 mL 1.4479 mL
50 mM 0.0463 mL 0.2317 mL 0.4633 mL 1.1583 mL
60 mM 0.0386 mL 0.1931 mL 0.3861 mL 0.9653 mL
80 mM 0.0290 mL 0.1448 mL 0.2896 mL 0.7240 mL
100 mM 0.0232 mL 0.1158 mL 0.2317 mL 0.5792 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Peimine Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Peimine23496-41-5Verticine DihydroisoimperialineApoptosisInterleukin RelatedTNF Receptorp38 MAPKNF-κBILTumor Necrosis Factor ReceptorTNFRNuclear factor-κBNuclear factor-kappaBprostate cancerintracellular calcium homeostasisapoptosisLPS-induced acute lung injury in miceinflammatoryNav1.7 ion channelKv1.3 ion channelInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Peimine
Cat. No.:
HY-N0212
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.